- Filed
- Oct 28, 2020 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2020 · Oct 26, 2020 | 349.65M sh |
| Long Term Debt | Q3 2020 · Sep 30, 2020 | $4.3B |
| Cash And Equivalents | Q3 2020 · Sep 30, 2020 | $803.09M |
| Cash And Equivalents | Q3 2020 · Dec 31, 2019 | $345.19M |
| Current Liabilities | Q3 2020 · Sep 30, 2020 | $2.21B |
| Current Liabilities | Q3 2020 · Dec 31, 2019 | $2.11B |
| Total Liabilities | Q3 2020 · Sep 30, 2020 | $6.96B |
| Total Liabilities | Q3 2020 · Dec 31, 2019 | $8.22B |
| Current Assets | Q3 2020 · Sep 30, 2020 | $2.41B |
| Current Assets | Q3 2020 · Dec 31, 2019 | $1.82B |
| Total Assets | Q3 2020 · Sep 30, 2020 | $6.04B |
| Total Assets | Q3 2020 · Dec 31, 2019 | $5.56B |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 281.19M sh |
| Shares Diluted | Q3 2020 · Sep 30, 2019 | 280.06M sh |
| Stock Repurchased | Q3 2020 · Sep 30, 2019 | $2.74M |
| Capex | Q3 2020 · Sep 30, 2019 | $89.4M |
| Operating Cash Flow | Q3 2020 · Sep 30, 2019 | $313.72M |
| Stockholders Equity | Q3 2020 · Sep 30, 2019 | −$2.6B |
| Stockholders Equity | Q3 2020 · Jun 30, 2019 | −$2.59B |
| Stockholders Equity | Q3 2020 · Dec 31, 2018 | −$1.52B |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | $0.09 |
| Eps Diluted | Q3 2020 · Sep 30, 2019 | $0.17 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | $0.10 |
| Eps Basic | Q3 2020 · Sep 30, 2019 | $0.17 |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $227M |
| Sga Expense | Q3 2020 · Sep 30, 2019 | $681.43M |
| Net Income | Q3 2020 · Sep 30, 2019 | $15.42M |
| Net Income | Q3 2020 · Sep 30, 2019 | $31.07M |
| Operating Income | Q3 2020 · Sep 30, 2019 | $118.7M |
| Operating Income | Q3 2020 · Sep 30, 2019 | $303.93M |
| Revenue | Q3 2020 · Sep 30, 2019 | $1.02B |
| Revenue | Q3 2020 · Sep 30, 2019 | $2.98B |